Cytokinetics CYTK Balance Sheet (2010-2026)

NASDAQ CYTK
$72.72 -1.23 (-1.66%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Cytokinetics Quarterly Balance Sheet

Periods 64 quarters
Latest Jun 2026

Cytokinetics reported total assets of $1924.55M and total liabilities of $2098.04M for the quarter ended Jun 2026, up 57.0% year over year. This balance sheet covers 64 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2010 Sep2010 Dec2010 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
90.56M112.67M115.42M93.63M106.24M67.18M103.22M69.01M100.07M113.40M120.35M190.52M47.26M95.23M74.06M76.55M225.47M122.52M129.84M255.27M
Short-term InvestmentsInvestments (Current)
387.07M358.97M493.55M492.39M761.43M717.00M562.35M497.08M439.55M501.80M498.99M866.63M964.80M981.16M864.54M783.20M737.07M759.70M688.71M910.41M
Cash & Current Investments
477.64M471.64M608.97M586.03M867.66M784.18M665.56M566.10M539.61M615.20M619.34M1,057.15M1,012.07M1,076.39M938.59M859.75M962.53M882.22M818.55M1,165.69M
Receivables - NetNet Receivables
0.64M51.82M6.06M1.97M2.29M0.15M1.01M0.98M2.50M1.28M0.83M0.24M16.65M2.01M8.41M1.81M17.76M6.83M24.43M
Receivables - OtherOther Receivables
Receivables
0.64M51.82M6.06M1.97M2.29M0.15M1.01M0.98M2.50M1.28M0.83M0.24M16.65M2.01M8.41M1.81M17.76M6.83M24.43M
Raw Materials
5.54M
Work In Process
0.99M
Finished Goods
0.15M0.38M
Inventory
0.15M0.38M
Prepaid Assets
16.66M12.21M8.50M14.25M14.32M12.46M15.66M19.87M19.68M11.94M18.91M11.04M6.67M15.28M15.82M20.00M13.01M16.99M13.93M17.99M
Current Assets
494.94M535.67M623.53M602.25M884.27M795.19M680.63M586.58M561.42M628.05M638.70M1,067.81M1,018.60M1,107.94M956.05M886.54M977.35M916.98M839.47M1,208.49M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
53.90M73.27M75.74M78.59M80.30M80.45M78.86M77.25M75.61M68.75M68.02M65.69M64.22M65.81M67.17M70.22M76.00M79.19M82.44M78.92M
Long-Term Investments
191.29M152.05M77.08M10.67M28.54M46.71M40.41M26.87M15.47M40.53M15.38M305.36M269.17M145.06M150.69M178.20M288.82M335.05M254.72M538.32M
Other Non-Current Assets
6.68M7.19M7.26M8.05M7.76M9.69M8.12M8.34M8.19M8.00M7.81M7.68M7.72M7.71M12.70M14.55M16.81M17.34M18.47M19.41M
Non-Current Assets
332.60M305.65M232.73M169.47M191.69M219.59M209.19M193.32M179.20M196.26M169.38M455.98M417.46M293.73M308.00M339.09M459.21M507.56M434.01M716.06M
Assets
827.54M841.32M856.25M771.72M1,075.96M1,014.77M889.82M779.90M740.61M824.32M808.08M1,523.79M1,436.06M1,401.67M1,264.05M1,225.63M1,436.56M1,424.54M1,273.48M1,924.55M
Liabilities
Current Liabilities
Accounts Payables
16.22M21.09M19.84M14.08M14.43M25.61M17.36M12.56M13.80M21.51M12.97M9.47M11.58M20.37M13.94M16.23M22.08M22.34M24.71M20.51M
Notes Payables
13.20M12.50M11.30M11.70M17.60M16.90M31.10M29.60M30.70M
Payables
16.22M21.09M19.84M14.08M14.43M25.61M17.36M12.56M13.80M21.51M12.97M22.67M24.08M31.67M25.64M33.83M38.98M53.44M54.31M51.21M
Accumulated Expenses
31.77M34.37M29.48M36.70M40.23M44.10M35.63M31.47M32.95M42.64M40.12M39.81M49.83M55.32M43.36M52.31M61.63M83.28M68.86M76.86M
Other Accumulated Expenses
4.97M5.57M4.86M7.69M10.12M6.22M10.71M6.38M13.74M10.56M14.79M10.27M10.69M9.81M8.51M9.59M12.03M13.57M17.53M21.36M
Short term Debt
16.88M0.96M10.08M11.52M11.52M11.52M11.52M12.96M14.40M17.28M41.18M44.81M27.36M
Current Leases
13.59M14.86M14.49M14.30M16.06M12.83M14.26M15.70M17.24M17.89M18.23M18.51M18.86M18.98M19.57M19.59M20.65M19.11M20.96M21.04M
Current Deferred Revenue
52.37M52.37M1.34M1.61M1.61M1.65M1.65M
Total Current Liabilities
80.87M71.86M66.85M66.84M76.50M84.62M75.22M65.62M77.72M102.68M88.86M102.78M109.81M179.67M159.73M131.06M142.14M202.45M199.19M181.43M
Non-Current Liabilities
Non-Current Debt
30.20M47.37M61.16M62.34M63.54M63.81M64.11M62.49M60.88M58.38M56.82M92.83M93.02M93.23M92.03M159.06M158.75M246.38M247.21M248.20M
Convertible Debt
93.89M95.47M134.51M134.67M544.99M545.81M546.51M547.29M548.13M548.99M549.79M550.60M551.48M552.37M553.14M553.99M889.52M869.60M870.51M871.53M
Non-Current Deffered Revenue
87.00M87.00M87.00M
Operating Leases
112.23M112.02M112.73M114.41M126.89M125.34M123.83M122.22M120.43M118.55M116.72M114.75M112.58M113.35M111.03M110.66M107.97M105.23M102.43M
Other Non-Current Liabilities
174.80M4.46M3.21M1.44M1.25M1.04M0.84M0.62M0.41M0.19M0.00M2.82M2.02M1.61M31.10M29.60M30.70M
Total Non-Current Liabilities
403.72M593.00M736.78M658.86M1,090.69M1,121.63M1,118.00M1,112.39M1,179.01M1,210.45M1,204.24M1,415.24M1,449.97M1,537.05M1,527.64M1,592.34M1,956.07M2,053.06M2,070.45M2,067.34M
Total Liabilities
578.52M597.46M739.99M660.30M1,091.94M1,122.67M1,118.84M1,113.01M1,179.41M1,210.64M1,204.24M1,415.24M1,449.97M1,537.05M1,530.46M1,594.36M1,957.68M2,084.16M2,100.05M2,098.04M
Shareholder's Equity
Total Debt
47.08M47.37M61.16M62.34M63.54M64.77M64.11M62.49M60.88M68.46M68.34M117.55M117.04M116.05M116.69M191.06M192.93M318.67M321.62M306.26M
Common Equity
249.02M243.86M116.26M111.41M-15.98M-107.90M-229.02M-333.12M-438.80M-386.32M-396.16M108.55M-13.91M-135.37M-266.41M-368.72M-521.12M-659.62M-826.57M-173.49M
Liabilities and Shareholders Equity
827.54M841.32M856.25M771.72M1,075.96M1,014.77M889.82M779.90M740.61M824.32M808.08M1,523.79M1,436.06M1,401.67M1,264.05M1,225.63M1,436.56M1,424.54M1,273.48M1,924.55M
Retained Earnings
-1177.10M1,452.27M-1286.50M-1306.30M-1448.61M-1585.99M-1717.28M-1845.92M-2000.00M-2112.24M-2247.88M-2400.00M-2600.00M-2701.76M-2900.00M-3000.00M-3303.69M-3486.72M-3700.00M-3900.00M
Preferred Shares